Developer docs
API playgroundTry for free, no card

Search company profiles

Axios International

Full company profile

uuid002k8uv

Namestring
Axios International
Legal namestring
Axios International Consultants Ltd
Websiteurl
axiosint.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Axios International is a privately held, Irish-domiciled (Axios International Consultants Ltd) healthcare access solutions provider that designs, manages, and operates patient access and support programs for pharmaceutical clients, healthcare providers, and patients. The company has been operating for approximately 25 years (founded around 1999; firmographic listing cites 1997) and currently runs 240+ active programs across 40+ countries. Its customers span pharmaceutical companies (primary), healthcare providers and physicians, healthcare systems and government ministries, pharmacists, and patients with chronic and rare diseases, with named engagements including the Ministry of Health Malaysia and the National Cancer Society Malaysia.

The company operates a dual-platform architecture. Axios Access Solutions comprises service-based modules — Access Strategy Consulting, Access to Diagnosis, Access to Treatment Solutions, Access to Maximized Adherence, and Remote Care — supported by proprietary tools (PFET for patient financial eligibility, PNAT for patient-needs assessment, Affordability and Economic Modeling, Access Prioritization Tool, and Willingness to Pay and Prescribe Studies). Axios+ is a digital health ecosystem of role-specific applications: MyPatients for physicians, MyHealth for patients, MyPharmacy for pharmacists, MyPrograms for pharmaceutical sponsors, and MyCharity for charitable partners. The newest addition is the On-Time Access (OTA) model, launched in 2024, which addresses cash-flow barriers that delay initiation of specialty medications.

Revenue is generated through three streams: patient access program management (managed services), access strategy consulting (professional services), and digital health platforms under Axios+ (subscription / recurring). Pricing is not publicly disclosed; the go-to-market is direct enterprise sales targeting pharmaceutical companies and healthcare organizations, with no distribution through third-party resellers. The company is founder-led, with Joseph Saba, MD serving as CEO and co-founder, and is governed under Irish law with no parent entity, no disclosed institutional investors, no funding rounds, and no M&A history in the available records.

Short descriptiontext

Axios International is a privately held, Irish-headquartered healthcare access solutions provider that designs and operates patient access and support programs for pharmaceutical companies, providers, and patients across 40+ countries. It combines managed services, consulting, proprietary tools, and the Axios+ digital health platform spanning physicians, patients, pharmacists, pharma sponsors, and charities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersDubai, United Arab Emirates
HQ citystring
Dubai
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
patient access programs, healthcare access consulting, medication adherence solutions, pharmaceutical access strategy, patient support services
Industry4 codes
PRIMARYHLAIAKAG
HLAIAKAG
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLACAKAG
HLACAKAG
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLALAIAF
HLALAIAF
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALAIAG
HLALAIAG
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
NAICS code2 codes
  • 54169
  • 541690
SIC code1 code
  • 8742
Product category
Healthcare Access Solutions
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Patient Access Program Management
TypeManaged Services
Description

Axios designs and manages patient access and support programs for pharmaceutical companies, helping patients access treatments through programs that address financial barriers, adherence support, and treatment initiation

axiosint.com
2Access Strategy Consulting
TypeProfessional Services
Description

Consulting services to help pharmaceutical companies develop access strategies for their products in various markets, including pricing, reimbursement, and distribution strategies

axiosint.com
3Digital Health Solutions
TypeSubscription Recurring
Description

SaaS platforms and digital tools (MyPatients, MyHealth, MyPharmacy, MyPrograms, MyCharity) provided to healthcare providers, patients, pharmacists, and pharmaceutical companies

axiosint.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1MyPatients
Description

App for physicians to manage patient care

axiosint.com
+4 more records
Core offering1 text field

Axios International designs and manages patient access and support programs on behalf of pharmaceutical companies, helping patients overcome financial, diagnostic, and adherence barriers to specialty medications. Its offerings span access strategy consulting, diagnosis access, treatment access, adherence maximization, and remote care services, enabled by proprietary tools (PFET, PNAT, Affordability Modeling, Access Prioritization) and the Axios+ digital health ecosystem of physician, patient, pharmacist, pharma, and charity applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Adherence to long-term therapy for chronic illnesses averages 50% in developed countries, with even lower rates in low- and middle-income countries - Axios aims to improve these rates through personalized adherence interventions
Product overview1 text field

Axios International operates a dual-platform architecture consisting of Axios Access Solutions (consulting and service-based access programs) and Axios+ (digital health ecosystem). Axios Access Solutions provides a comprehensive suite including strategy consulting, access to diagnosis, treatment access, adherence maximization, and remote care solutions, supported by tools like PFET, PNAT, and Affordability Modeling. Axios+ is a digital health platform comprising five applications: MyPatients (physician app), MyHealth (patient app), MyPharmacy (pharmacist app), MyPrograms (pharma company web app), and MyCharity (charity portal). The company also introduced the On-Time Access (OTA) model as an innovative approach to overcome patient access barriers.

Product and service8 records
1Axios Access Solutions
CategoryPatient Access Services
Description

End-to-end suite of healthcare access services for pharmaceutical companies covering strategy consulting, patient diagnosis access, treatment access, adherence maximization, and remote care, designed to improve patient outcomes and healthcare system sustainability.

2Access Strategy Consulting
CategoryConsulting Services
Description

Consulting service helping pharmaceutical companies develop market access strategies, including affordability modeling, willingness-to-pay studies, and access prioritization analyses.

3Access to Diagnosis
CategoryPatient Access Services
Description

Solutions focused on improving patient access to diagnostic services and testing, supporting earlier identification of conditions that require specialty treatment.

4Access to Treatment Solutions
CategoryPatient Access Services
Description

Programs that help patients overcome financial and administrative barriers to accessing specialty medications, including the On-Time Access (OTA) model for addressing cash-flow constraints that delay treatment initiation.

5Access to Maximized Adherence
CategoryPatient Support Services
Description

Services designed to improve patient treatment adherence through personalized interventions, supported by the PNAT assessment tool, aimed at chronic and long-term therapies.

6Remote Care Solutions
CategoryRemote Care Services
Description

Digital health services providing remote healthcare delivery, monitoring, and patient support capabilities that supplement traditional in-person care.

7Axios+ Digital Health Platform
CategoryDigital Health Platform
Description

Digital health ecosystem providing patient, physician, pharmacist, pharmaceutical, and charity-facing applications that operationalize and manage patient access and support programs.

8On-Time Access (OTA) Model
CategoryPatient Access Model
Description

Innovative access model designed to overcome financial and administrative barriers to specialty medications by addressing cash-flow challenges that delay treatment initiation.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to announce an access-focused pharmacy initiative, combining Axios' expertise in patient access solutions with Dar Al Ber Society's charitable healthcare mission to improve medication accessibility

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Provider of cloud-based software for the pharma industry, including patient and commercial platforms. Veeva's expanding software stack overlaps with Axios+' MyPrograms-style pharma program management capabilities and could compete for digital tooling spend.

TypeDirect peer
Description

Commercial services firm providing patient access, hub, adherence, and market access services to pharmaceutical manufacturers. Direct overlap with Axios' patient support program management and access-to-treatment offerings.

TypeBroad incumbent
Description

Large CRO and pharma services provider with patient access and commercial services capabilities. While broader in scope, Parexel competes with Axios on access strategy and patient program engagements for biopharma sponsors.

4Decision Resources Group (DRG, part of Clarivate)
TypeEmerging player
Description

Provides market access insights, pricing data, and analytics for pharma companies, overlapping with Axios' Willingness to Pay/Prescribe studies, access prioritization, and affordability modeling tools.

TypeBroad incumbent
Description

Global leader in healthcare data, analytics, and pharma services with a substantial market access and patient services practice. Directly competes with Axios in access strategy consulting and patient support programs for pharmaceutical clients, but operates at much greater scale across a broader service portfolio.

6ZS Associates
TypeDirect peer
Description

Management consulting firm with deep pharma specialization, particularly in market access, pricing, and patient access strategy. Competes with Axios on access strategy consulting engagements and serves many of the same pharmaceutical clients with overlapping offerings.

TypeDirect peer
Description

Life sciences practice that advises pharmaceutical and biotech clients on market access, pricing, and commercial strategy, overlapping directly with Axios' access strategy consulting engagements.

TypeDirect peer
Description

Specialized pharma consulting firm offering market access, commercial strategy, and patient services insights that overlap with Axios' consulting and willingness-to-pay/adherence offerings for pharma clients.

TypeDirect peer
Description

Through its Lash Group and PharmaLex units, AmerisourceBergen offers patient access, hub, and patient support program services that directly overlap with Axios' core PSP and adherence offerings to pharma manufacturers.

TypeBroad incumbent
Description

Global management consulting firm whose pharma practice covers market access, pricing, and patient services strategy. Competes with Axios' Access Strategy Consulting offering on the most strategic access engagements with large pharma clients.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Axios International

Healthcare Access Solutionsaxiosint.com

Axios International is a privately held, Irish-headquartered healthcare access solutions provider that designs and operates patient access and support programs for pharmaceutical companies, providers, and patients across 40+ countries. It combines managed services, consulting, proprietary tools, and the Axios+ digital health platform spanning physicians, patients, pharmacists, pharma sponsors, and charities.

What Axios International does

Axios International is a privately held, Irish-domiciled (Axios International Consultants Ltd) healthcare access solutions provider that designs, manages, and operates patient access and support programs for pharmaceutical clients, healthcare providers, and patients. The company has been operating for approximately 25 years (founded around 1999; firmographic listing cites 1997) and currently runs 240+ active programs across 40+ countries. Its customers span pharmaceutical companies (primary), healthcare providers and physicians, healthcare systems and government ministries, pharmacists, and patients with chronic and rare diseases, with named engagements including the Ministry of Health Malaysia and the National Cancer Society Malaysia.

The company operates a dual-platform architecture. Axios Access Solutions comprises service-based modules — Access Strategy Consulting, Access to Diagnosis, Access to Treatment Solutions, Access to Maximized Adherence, and Remote Care — supported by proprietary tools (PFET for patient financial eligibility, PNAT for patient-needs assessment, Affordability and Economic Modeling, Access Prioritization Tool, and Willingness to Pay and Prescribe Studies). Axios+ is a digital health ecosystem of role-specific applications: MyPatients for physicians, MyHealth for patients, MyPharmacy for pharmacists, MyPrograms for pharmaceutical sponsors, and MyCharity for charitable partners. The newest addition is the On-Time Access (OTA) model, launched in 2024, which addresses cash-flow barriers that delay initiation of specialty medications.

Revenue is generated through three streams: patient access program management (managed services), access strategy consulting (professional services), and digital health platforms under Axios+ (subscription / recurring). Pricing is not publicly disclosed; the go-to-market is direct enterprise sales targeting pharmaceutical companies and healthcare organizations, with no distribution through third-party resellers. The company is founder-led, with Joseph Saba, MD serving as CEO and co-founder, and is governed under Irish law with no parent entity, no disclosed institutional investors, no funding rounds, and no M&A history in the available records.

Axios International firmographics

Firmographics
Name
Axios International
Legal name
Axios International Consultants Ltd
Website
https://axiosint.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
251–500 employees
Short description
Axios International is a privately held, Irish-headquartered healthcare access solutions provider that designs and operates patient access and support programs for pharmaceutical companies, providers, and patients across 40+ countries. It combines managed services, consulting, proprietary tools, and the Axios+ digital health platform spanning physicians, patients, pharmacists, pharma sponsors, and charities.
Ownership category
akta.pro rank

Where Axios International is headquartered

Location

Headquarters

HQ city
Dubai
HQ country
United Arab Emirates
HQ region
Middle East

Markets served

Axios International business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Patient Access Program Management: Axios designs and manages patient access and support programs for pharmaceutical companies, helping patients access treatments through programs that address financial barriers, adherence support, and treatment initiation
  2. Access Strategy Consulting: Consulting services to help pharmaceutical companies develop access strategies for their products in various markets, including pricing, reimbursement, and distribution strategies
  3. Digital Health Solutions: SaaS platforms and digital tools (MyPatients, MyHealth, MyPharmacy, MyPrograms, MyCharity) provided to healthcare providers, patients, pharmacists, and pharmaceutical companies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Axios International product offering

Product offering

Core offering

Axios International designs and manages patient access and support programs on behalf of pharmaceutical companies, helping patients overcome financial, diagnostic, and adherence barriers to specialty medications. Its offerings span access strategy consulting, diagnosis access, treatment access, adherence maximization, and remote care services, enabled by proprietary tools (PFET, PNAT, Affordability Modeling, Access Prioritization) and the Axios+ digital health ecosystem of physician, patient, pharmacist, pharma, and charity applications.

Product overview

Axios International operates a dual-platform architecture consisting of Axios Access Solutions (consulting and service-based access programs) and Axios+ (digital health ecosystem). Axios Access Solutions provides a comprehensive suite including strategy consulting, access to diagnosis, treatment access, adherence maximization, and remote care solutions, supported by tools like PFET, PNAT, and Affordability Modeling. Axios+ is a digital health platform comprising five applications: MyPatients (physician app), MyHealth (patient app), MyPharmacy (pharmacist app), MyPrograms (pharma company web app), and MyCharity (charity portal). The company also introduced the On-Time Access (OTA) model as an innovative approach to overcome patient access barriers.

Differentiator

Problem solved

Functional benefit

Brands

  • MyPatients: App for physicians to manage patient care
  • MyHealth
  • MyPharmacy
  • MyPrograms
  • MyCharity

Products and services

  • Axios Access Solutions End-to-end suite of healthcare access services for pharmaceutical companies covering strategy consulting, patient diagnosis access, treatment access, adherence maximization, and remote care, designed to improve patient outcomes and healthcare system sustainability.
  • Access Strategy Consulting Consulting service helping pharmaceutical companies develop market access strategies, including affordability modeling, willingness-to-pay studies, and access prioritization analyses.
  • Access to Diagnosis Solutions focused on improving patient access to diagnostic services and testing, supporting earlier identification of conditions that require specialty treatment.
  • Access to Treatment Solutions Programs that help patients overcome financial and administrative barriers to accessing specialty medications, including the On-Time Access (OTA) model for addressing cash-flow constraints that delay treatment initiation.
  • Access to Maximized Adherence Services designed to improve patient treatment adherence through personalized interventions, supported by the PNAT assessment tool, aimed at chronic and long-term therapies.
  • Remote Care Solutions Digital health services providing remote healthcare delivery, monitoring, and patient support capabilities that supplement traditional in-person care.
  • Axios+ Digital Health Platform Digital health ecosystem providing patient, physician, pharmacist, pharmaceutical, and charity-facing applications that operationalize and manage patient access and support programs.
  • On-Time Access (OTA) Model Innovative access model designed to overcome financial and administrative barriers to specialty medications by addressing cash-flow challenges that delay treatment initiation.

Quantifiable outcome

  • Adherence to long-term therapy for chronic illnesses averages 50% in developed countries, with even lower rates in low- and middle-income countries - Axios aims to improve these rates through personalized adherence interventions

Companies that use Axios International

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Axios International technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature11 records

Axios International partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Dar Al Ber SocietycoreStrategic or Co-development PartnerPartnership to announce an access-focused pharmacy initiative, combining Axios' expertise in patient access solutions with Dar Al Ber Society's charitable healthcare mission to improve medication accessibility

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Axios International competitors and assessment

Company assessment

Emerging players

  • Veeva Systems: Provider of cloud-based software for the pharma industry, including patient and commercial platforms. Veeva's expanding software stack overlaps with Axios+' MyPrograms-style pharma program management capabilities and could compete for digital tooling spend.
  • Decision Resources Group (DRG, part of Clarivate): Provides market access insights, pricing data, and analytics for pharma companies, overlapping with Axios' Willingness to Pay/Prescribe studies, access prioritization, and affordability modeling tools.

Direct peers

  • Eversana: Commercial services firm providing patient access, hub, adherence, and market access services to pharmaceutical manufacturers. Direct overlap with Axios' patient support program management and access-to-treatment offerings.
  • ZS Associates: Management consulting firm with deep pharma specialization, particularly in market access, pricing, and patient access strategy. Competes with Axios on access strategy consulting engagements and serves many of the same pharmaceutical clients with overlapping offerings.
  • Charles River Associates (CRA): Life sciences practice that advises pharmaceutical and biotech clients on market access, pricing, and commercial strategy, overlapping directly with Axios' access strategy consulting engagements.
  • Trinity Life Sciences: Specialized pharma consulting firm offering market access, commercial strategy, and patient services insights that overlap with Axios' consulting and willingness-to-pay/adherence offerings for pharma clients.
  • AmerisourceBergen (Lash Group / PharmaLex): Through its Lash Group and PharmaLex units, AmerisourceBergen offers patient access, hub, and patient support program services that directly overlap with Axios' core PSP and adherence offerings to pharma manufacturers.

Broad incumbents

  • Parexel International: Large CRO and pharma services provider with patient access and commercial services capabilities. While broader in scope, Parexel competes with Axios on access strategy and patient program engagements for biopharma sponsors.
  • IQVIA: Global leader in healthcare data, analytics, and pharma services with a substantial market access and patient services practice. Directly competes with Axios in access strategy consulting and patient support programs for pharmaceutical clients, but operates at much greater scale across a broader service portfolio.
  • McKinsey & Company (Pharma Practice): Global management consulting firm whose pharma practice covers market access, pricing, and patient services strategy. Competes with Axios' Access Strategy Consulting offering on the most strategic access engagements with large pharma clients.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Axios International social profiles

Digital presence

Axios International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Axios International leadership team

Management profile

Number of profiles

Profiles1 record

Axios International funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Axios International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axios International

What does Axios International do?

Axios International designs and manages patient access and support programs on behalf of pharmaceutical companies, helping patients overcome financial, diagnostic, and adherence barriers to specialty medications. Its offerings span access strategy consulting, diagnosis access, treatment access, adherence maximization, and remote care services, enabled by proprietary tools (PFET, PNAT, Affordability Modeling, Access Prioritization) and the Axios+ digital health ecosystem of physician, patient, pharmacist, pharma, and charity applications.

Is Axios International a public or private company?

Axios International is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Axios International founded?

Axios International was founded in 1999. It employs 251 to 500 people.

Where is Axios International based?

Axios International is headquartered in Dubai, United Arab Emirates, in the Middle East region.

How does Axios International make money?

Three revenue lines are on record. Patient Access Program Management is the primary driver. The others are access Strategy Consulting and digital Health Solutions.

Who are Axios International's main competitors?

Emerging players on record are Veeva Systems and Decision Resources Group (DRG, part of Clarivate). Direct peers are Eversana, ZS Associates, Charles River Associates (CRA), Trinity Life Sciences and AmerisourceBergen (Lash Group / PharmaLex). Broad incumbents are Parexel International, IQVIA and McKinsey & Company (Pharma Practice).

Does Axios International have an API?

No public API is recorded for Axios International.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales